Study on a low-flow CO2 removal device for breathing failure
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks back at medical records of people who used a special device (ECCO2R) in the ICU to help remove carbon dioxide from the blood. The goal is to see if the device is safe and works well for patients with breathing problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been treated with the ECCO2R device while in the hospital.
- You must have been in the ICU between January 1, 2022 and June 30, 2024.
- You must be 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new breathing device that may be as accurate as standard tests for diagnosing asthma and COPD. It could offer a simpler and quicker way to check your lung health.
This study tests a machine that removes carbon dioxide from your blood (called extracorporeal carbon dioxide removal or ECCO2R) to help protect your lungs from further damage while on a breathing machine. It may be an option if you have severe ARDS and your breathing machine settings are very high.
This study tests a machine that removes carbon dioxide from the blood to help people with severe COPD breathe easier when noninvasive ventilation (a mask that helps breathing) is not enough. It aims to avoid the need for a breathing tube.
This trial tests a device called PrismaLung+ that helps remove extra carbon dioxide from the blood of patients on breathing machines. It may help people whose lungs are struggling despite gentle ventilation settings.
This study tests an “extra-CO2 removal” breathing support approach to help protect the lungs in people with moderate ARDS, a serious lung injury. You would be on a ventilator for a short time, and the team would check whether this approach improves breathing outcomes while aiming to be safer for the lungs.
This study is testing an existing model (BREF) to see how well it helps doctors make decisions for patients on high-flow oxygen in the intensive care unit. It may help improve care for people needing extra breathing support.
Hear when a new Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.